Sarcoidosis during infliximab therapy for Crohn's disease

被引：21

作者：

Takahashi, Hidetoshi ^{[1
]}

Kaneta, Kazuhiro ^{[1
]}

Honma, Masaru ^{[1
]}

Ishida-Yamamoto, Akemi ^{[1
]}

Ashida, Tomonori ^{[2
]}

Kohgo, Yutaka ^{[2
]}

Ohsaki, Yoshinobu ^{[3
]}

Iizuka, Hajime ^{[1
]}

机构：

[1] Asahikawa Med Coll, Dept Dermatol, Asahikawa, Hokkaido 0788510, Japan

[2] Asahikawa Med Coll, Dept Internal Med 3, Asahikawa, Hokkaido 0788510, Japan

[3] Asahikawa Med Coll, Dept Internal Med 1, Asahikawa, Hokkaido 0788510, Japan

来源：

JOURNAL OF DERMATOLOGY | 2010年 / 37卷 / 05期

关键词：

infliximab; psoriasiform eruption; tumor necrosis factor-alpha; TUMOR-NECROSIS-FACTOR; PULMONARY SARCOIDOSIS; ETANERCEPT THERAPY; ARTHRITIS; PATIENT;

D O I：

10.1111/j.1346-8138.2010.00861.x

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Tumor necrosis factor-alpha (TNF-alpha) antagonists are effective for inflammatory diseases, such as Crohn's disease, rheumatoid arthritis (RA) and psoriasis. Although TNF-alpha antagonists are also useful for sarcoidosis, paradoxical occurrence of sarcoidosis or sarcoidal reaction may be observed. We report a Crohn's disease patient, who developed sarcoidosis during infliximab therapy. A 35-year-old man had been receiving infliximab for 7 months for Crohn's disease. He developed cough and fever, accompanied by an infiltrated erythematous plaque on his right knee. The chest radiography, skin biopsy and laboratory findings were all consistent with sarcoidosis.

引用

页码：471 / 474

页数：4

共 50 条

[21] Ineffectiveness of infliximab therapy in severe infantile Crohn's disease
Uslu, Nuray
Usta, Yusuf
Saltik-Temizel, Inci Nur
Demir, Hulya
Gurakan, Figen
Ozen, Hasan
Yuce, Aysel
[J]. JOURNAL OF CROHNS & COLITIS, 2010, 4 (01) : 106 - 109
[22] Intensification of infliximab therapy in Crohn's disease: Efficacy and safety
Chaparro, M.
Martinez-Montiel, P.
Van Domselaar, M.
Bermejo, F.
Perez-Calle, J. L.
Casis, B.
Lopez-San Roman, A.
Algaba, A.
Mate, J.
Gisbert, J. P.
[J]. JOURNAL OF CROHNS & COLITIS, 2012, 6 (01) : 62 - 67
[23] Brain Abscesses in Crohn's Disease as a Complication of Infliximab Therapy
Mansour, Mahmoud M.
Mubarak, Muhammad
Chela, Harleen
Ghouri, Yezaz A.
[J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (06)
[24] Herpes zoster in Crohn's disease during treatment with infliximab
Wang, Xiaobing
Zhao, Junzhang
Zhu, Siying
Xia, Bing
[J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2014, 26 (02) : 237 - 239
[25] Characteristics of Faecal Microbiota in Paediatric Crohn's Disease and Their Dynamic Changes During Infliximab Therapy
Wang, Yizhong
Gao, Xuefeng
Ghozlane, Amine
Hu, Hui
Li, Xiaolu
Xiao, Yongmei
Li, Dan
Yu, Guangjun
Zhang, Ting
[J]. JOURNAL OF CROHNS & COLITIS, 2018, 12 (03) : 337 - 346
[26] Pneumocystis Pneumonia During Combined Therapy of Infliximab, Corticosteroid, and Azathioprine in a Patient with Crohn’s Disease
Soichi Itaba
Tsutomu Iwasa
Yojiro Sadamoto
Toshifumi Nasu
Tadashi Misawa
Koji Inoue
Hidehiko Shimokawa
Kazuhiko Nakamura
Ryoichi Takayanagi
[J]. Digestive Diseases and Sciences, 2007, 52 : 1438 - 1441
[27] Pneumocystis pneumonia during combined therapy of infliximab, corticosteroid, and azathioprine in a patient with Crohn's disease
Itaba, Soichi
Iwasa, Tsutomu
Sadamoto, Yojiro
Nasu, Toshifumi
Misawa, Tadashi
Inoue, Koji
Shimokawa, Hidehiko
Nakamura, Kazuhiko
Takayanagi, Ryoichi
[J]. DIGESTIVE DISEASES AND SCIENCES, 2007, 52 (06) : 1438 - 1441
[28] Severe Legionella pneumophila Pneumonia Following Infliximab Therapy in a Patient with Crohn's Disease
Beigel, Florian
Juergens, Matthias
Filik, Levent
Bader, Lutz
Lueck, Christian
Goeke, Burkhard
Ochsenkuehn, Thomas
Brand, Stephan
Seiderer, Julia
[J]. INFLAMMATORY BOWEL DISEASES, 2009, 15 (08) : 1240 - 1244
[29] Increases in body mass index during infliximab therapy in patients with Crohn's disease: An open label prospective study
Nakahigashi, Maki
Yamamoto, Takayuki
[J]. CYTOKINE, 2011, 56 (02) : 531 - 535
[30] Time of infliximab therapy initiation and dose escalation in Crohn's disease
Mindy CW Lam
Terry Lee
Kenneth Atkinson
Brian Bressler
[J]. World Journal of Gastroenterology, 2014, (01) : 214 - 218

← 1 2 3 4 5 →